Addiction Treatment Forum

Addiction Treatment Forum reports on substance use news of interest to opioid treatment programs and patients in medication-assisted treatment.

Government

Co-Occurring Disorders
Diversion/Overdose/Mortality
Miscellaneous
Regulations/Reports/Guidelines
Research and Surveys
Substance Abuse Workforce Development
TIPS/Quick Guides/KAP Keys/TAPS

Co-Occurring Disorders

Definitions and Terms Relating to Co-Occurring Disorders
April 2006.
This paper provides definitions of terms associated with substance-related disorders, mental disorders, co-occurring disorders, and programs.
pdficon_24X24Download PDF (533KB, 12pp)
SAMHSA Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorders
May 2012.
pdficon_24X24Download PDF (582KB, 18pp)
Screening, Assessment, and Treatment Planning for Persons With Co-Occurring Disorders
April 2006.
pdficon_24X24Download PDF (271KB, 10pp)

Diversion/Overdose/Mortality

overdoes5 Things to Know about Opioid Overdoses
Office of National Drug Control Policy – February 11, 2014.
http://www.whitehouse.gov/blog/2014/02/10/5-things-know-about-opioid-overdoses
Drug Overdose Deaths in the United States, 1999–2016
NCHS Data Brief December 2017.
pdficon_24X24Download PDF
GAO Report – Methadone-Associated Overdose Deaths
March 2009.
pdficon_24X24Download PDF (1.73 MB, 55pp)
Methadone-Associated Mortality: Report of a National Assessment
CSAT/DPT. February 2004.
pdficon_24X24Download PDF (428KB, 60 pp)
Methadone Diversion, Abuse, and Misuse: Deaths Increasing at Alarming Rate
U.S. Department of Justice National Drug Intelligence Center. November 2007.
pdficon_24X24Download PDF (20 pp)
Methadone Mortality – A Reassessment
CSAT/DPT. July 2007.
pdficon_24X24Download PDF (426 KB, 48 pp)
NARCAN Nasal Spray: Life-Saving Science at NIDA 
National Institute on Drug Abuse November 2015.
http://www.drugabuse.gov/about-nida/noras-blog/2015/11/narcan-nasal-spray-life-saving-science-nida
Opioid Abuse in the U.S. and HHS Actions to Address Opioid-Drug Related Overdose and Deaths – ASPE Issue Brief
HHS March 25, 2015.
pdficon_24X24 Download PDF (148KB, 12pp)
Overdose Death Rates 2001-2016
National Institute on Drug Abuse (NIDA) Updated September 2017.
http://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
Overdose prevention toolkitSAMHSA Opioid Overdose Prevention Toolkit (Updated)
Updated January 2016.
pdficon_24X24 Download PDF (302KB, 23pp)
Today’s Heroin Epidemic Infographics
Centers for Disease Control and Prevention July 2015.
http://www.cdc.gov/vitalsigns/heroin/infographic.html
home-featured-prescriptionUnderstanding the Prescription Drug Epidemic
Centers for Disease Control and Prevention (CDC) Updated April 30, 2015.
http://www.cdc.gov/drugoverdose/epidemic/index.html

Miscellaneous

SAMHSA Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide
March 2016.
PDF available for download (16 pp)
Medicaid: States’ Most Powerful Tool to Combat the Opioid Crisis Issue Brief
State Health Reform Assistance Network July 2016.
pdficon_24X24 PDF available for download (255 KB, 8pp)
The National Institute on Drug Abue (NIDA) Media Guide
Updated December 2012.The purpose of this guide is to give journalists fast and user-friendly access to the latest scientific information on drug abuse and addiction.PDF available at: https://www.drugabuse.gov/publications/media-guide/science-drug-abuse-addiction-basics
Medication Assisted Treatment for the 21st Century: Community Education Kit

OTPs can use the material in this kit to broaden their knowledge of methadone and other medication-related options for treating opioid dependence. The kit includes information on communicating effectively with key community stakeholders. Also included are suggestions for developing a coordinated community education effort aimed at reducing the stigma associated with opioid dependence and its service-delivery systems.

The kit can be ordered online.
State Opioid Treatment Authorities (SOTAs) <View contact list.> Not available as of November 22, 2017
Single State Agency Directory <View contact list.> Not available as of November 22 2017

Regulations/Reports/Guidelines

1997 NIH Consensus Statement – Effective Medical Treatment of Opioid Addiction
November 19, 1997.
PDF file Download PDF (48pp)
2001 Methadone Regulations Final Rule
Federal Register; January 17, 2001 [21 CFR Part 291; 42 CFR Part 8; Opioid Drugs in the Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule]
pdficon_24X24Download PDF (529KB, 28pp)
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Centers for Disease Control and Prevention. March 15, 2016.
pdficon_24X24Download PDF (699KB, 52pp)
CSAT Guidelines for the Accreditation of Opioid Treatment Programs
Revised July 20, 2007.
pdficon_24X24Download PDF (739KB, 77pp)
DEADrug Enforcement Agency (DEA) 2015 (U) Unclassified National Heroin Threat Assessment Summary
April 2015.
pdficon_24X24 Download PDF (6.02MB, 12pp)
Dear Colleague Letter: Final Rule on Buprenorphine Disipensing in Opioid Treatment Programs
December 6, 2012.
pdficon_24X24Download PDF (255KB, 11pp)
Federal Guidelines for Opioid Treatment Programs
SAMHSA March 2015.
pdficon_24X24Download PDF (1.22MB, 82pp)
Federal Register Notice Buprenorphine: Medication Assisted Treatment for Opioid Use Disorders – Increasing the Patient Cap
Health and Human Services Department July 8, 2016.
https://www.federalregister.gov/articles/2016/07/08/2016-16120/medication-assisted-treatment-for-opioid-use-disorders
criminal justice imageNIDA Principles of Drug Abuse Treatment for Criminal Justice Populations
January 2012.
pdficon_24X24Download PDF (1.42MB, 20pp)
NIDA Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition)
January 2018,
pdficon_24X24Download PDF (67pp)
Restatement of SAMHSA Guidance to OTPs on Take-home Doses
January 24, 2008.
pdficon_24X24Download PDF (149KB, 3pp)
SAMHSA Guidance on the Importance of Determining the Initial Methadone Dose
September 4, 2007.
pdficon_24X24Download PDF (115KB, 2pp)
SAMHSA Guidance Regarding Labeling for Take-home Medication Bottles
May 14, 2008.
pdficon_24X24Download PDF (448KB, 3pp)

Research and Surveys

Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health
September 2016.
pdficon_24X24Download PDF (2.16MB, 74pp)
NIDA Notes
NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.
http://www.drugabuse.gov/news-events/nida-notes
The Prescription Opioid Epidemic and Heroin Research Report Series
National Institute on Drug Abuse (NIDA) October 2015.
https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-abuse-heroin-use/introduction
SAMHSA Guidance Regarding Labeling for Take-home Medication Bottles
May 14, 2008.
pdficon_24X24Download PDF (448KB, 3pp)

Substance Abuse Workforce Development

TIPS/Quick Guides/KAP Keys/TAPS

TIP GeneralCSAT TIP Series
The Treatment Improvement Protocol (TIP) Series are best-practice guidelines for the treatment of substance abuse.
A complete listing of TIPS is available
CSAT TAP 21: Addiction Counseling Competencies
2006.
pdficon_24X24Download PDF (1.9 MB, 223pp)
CSAT TIP 40 Clincial Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
 2004.
pdficon_24X24Download PDF (1.1 MB, 198pp)
CSAT TIP 43 (MAT-TIP) Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
November 2005.
pdficon_24X24Download PDF (1.33MB, 356pp)
DoctorCSAT TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Treatment Programs Knowledge Application Program (KAP) Keys for Clinicians
May 2007.
 pdficon_24X24Download PDF (244KB, 22pp)
CSAT TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid Addiction Treatment Programs Quick Guide for Clinicians
May 2007.
This Quick Guide is based on TIP 43 and is designed to meet the needs of the busy clinician for concise, easily accessed how-to information.
pdficon_24X24Download PDF (215KB, 44pp)
CSAT TIP 47 Substance Abuse: Clinical Issues in Intensive Outpatient Treatment
2006.
pdficon_24X24Download PDF (853KB, 249pp)
CSAT TIP 52 Clinical Supervision and Professional Development of the Substance Counselor: Quick Guide for Administrators
October 2013.
pdficon_24X24Download PDF (318KB, 34pp)
CSAT TIP 53 Addressing Viral Hepatitis in People With Substance Use Disorders
 December 2011.
pdficon_24X24Download PDF (904KB, 146pp)
Hepatitis collageCSAT Tip 53 Addressing Viral Hepatitis in People With Substance Use Disorders – A Quick Guide for Clinicians and Administrators
November 2013.
pdficon_24X24Download PDF (601KB, 46pp)
CSAT Tip 53 Addressing Viral Hepatitis in People With Substance Use Disorders – KAP Keys for Clinicians
November 2013.
pdficon_24X24  Download PDF (235KB, 14pp)
CSAT TIP 54 Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders
January 2012.
pdficon_24X24Download PDF (1.05MB, 129pp)
CSAT TIP 54 Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders – A Quick Guide for Clinicians and Administrators
November 2013.pdficon_24X24 Download PDF (623KB, 48pp)
CSAT Tip 54 Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders KAP KEYS for Clinicians
November 2013.
pdficon_24X24 Download PDF (241KB, 14pp)
CSAT TIP 56 Addressing the Specific Behavioral Health Needs of Men
May 2013.
pdficon_24X24Download PDF (2.37MB, 247pp)
CSAT Tip 63 Medications for Opioid Use Disorder
2018.
pdficon_24X24SAMHSA TIP 63 ( 8.58MB, 306pp)

 All links accessed November 22, 2017.